Vascular biology of ageing—Implications in hypertension
Open accessAbstract
Ageing is associated with functional, structural and mechanical changes in arteries that closely resemble the vascular alterations in hypertension. Characteristic features of large and small arteries that occur with ageing and during the development of hypertension include endothelial dysfunction, vascular remodelling, inflammation, calcification and increased stiffness. Arterial changes in young hypertensive patients mimic those in old normotensive individuals. Hypertension accelerates and augments age-related vascular remodelling and dysfunction, and ageing may impact on the severity of vascular damage in hypertension, indicating close interactions between biological ageing and blood pressure elevation. Molecular and cellular mechanisms underlying vascular alterations in ageing and hypertension are common and include aberrant signal transduction, oxidative stress and activation of pro-inflammatory and pro-fibrotic transcription factors. Strategies to suppress age-associated vascular changes could ameliorate vascular damage associated with hypertension. An overview on the vascular biology of ageing and hypertension is presented and novel molecular mechanisms contributing to these processes are discussed. The complex interaction between biological ageing and blood pressure elevation on the vasculature is highlighted. This article is part of a Special Issue entitled: CV Ageing.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Advanced signs of cardiovascular aging such as tissue remodeling and cardiac hypertrophy are often preceded and may be initiated by malfunctioning aged endothelia.
“More recent work has also shown that advanced signs of cardiovascular aging such as tissue remodeling and cardiac hypertrophy are often preceded and may be initiated by the malfunctioning of aged endothelia50–52.”
From An inflammatory aging clock (iAge) based on deep learning tracks multimorbidity, immunosenescence, frailty and cardiovascular aging (2021) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 154 · Cited by 330
Research works printed but not linked: 2
- [41]Reyes-Toso C.F. Obaya-Naredo D. Ricci C.R. Planells F.M. Pinto J.E. Linares L.M. Exp Gerontol 42 4 2007 337 342 17116384
- [150]Wang M. Takagi G. Asai K. Resuello R.G. Natividad F.F. Aging increases aortic MMP-2 activity and angiotensin II in nonhuman primates Hypertension 41 2003 1308 1316 12743015
- Authors
- Harvey, A., Montezano, A. C., & Touyz, R. M.
- Affiliations
- University of Glasgow (GB)
- Corresponding author
- Touyz, Rhian M.
- Venue
- Journal of Molecular and Cellular Cardiology
- Publisher
- Elsevier BV
- Published
- 2015-06
- Volume
- 83
- Pages
- 112-121
- ISSN
- 0022-2828 (ISSN-L)
- PMC
- PMC4534766
- OpenAlex
- W2035902115
- Cited by
- 330
- References
- 154
- Citations by year
- 2026: 22 · 2025: 20 · 2024: 35 · 2023: 28 · 2022: 31 · 2021: 30 · 2020: 35 · 2019: 29 · 2018: 41 · 2017: 23 · 2016: 25 · 2015: 11
- FWCI
- 5.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Molecular and Cellular Cardiology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- Funders
- Canadian Institutes of Health Research (44018)
- British Heart Foundation (BHF) (57886, RG/13/7/30099)
- BHF Chair (CH/12/4/29762)
- University of Glasgow
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Keywords
- vascular aging, hypertension, endothelial dysfunction, vascular remodeling, arterial calcification, arterial stiffness, vascular inflammation, oxidative stress, signal transduction, transcription factors, vascular fibrosis, elevated blood pressure
- MeSH terms
- Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Src Homology 2 Domain-Containing, Transforming Protein 1, Aged, Aging, Animals, Blood Vessels, Endothelium, Vascular, Gene Expression Regulation, Humans, Hypertension, Myocardium, Transcription Factors, Signal Transduction, Oxidative Stress, Cell Cycle Proteins, Mitogen-Activated Protein Kinases, Forkhead Transcription Factors, Transforming Growth Factor beta1, Shc Signaling Adaptor Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review